BioLASCO Taiwan Market Cap

BioLASCO Taiwan has a market cap or net worth of 742.75 million as of April 29, 2026. Its market cap has decreased by -14.71% in one year.

Market Cap

742.75M

Enterprise Value

687.83M

Revenue

262.66M

Ranking

n/a

PE Ratio

17.58

Stock Price

29.10

Market Cap Chart

Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 742.75M, a decrease of -53.02%. That is a compound annual growth rate of -8.68%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	745.31M	-6.13%
Dec 31, 2025	793.97M	-6.34%
Dec 31, 2024	847.76M	-0.30%
Dec 29, 2023	850.32M	11.22%
Dec 30, 2022	764.52M	-1.97%
Dec 30, 2021	779.89M	-13.74%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Neith	793.51M
MegaPro Biomedical	799.30M
SynCore Biotechnology Co.,Ltd	698.02M
TaiwanJ Pharmaceuticals	657.80M
Vectorite Biomedical	650.00M
NatureWise Biotech & Medicals	897.75M
TCI GENE	1.01B
Lukas Biomedical	1.01B

Market Cap Rankings